Odyssey Health (ODYY) Cash from Investing Activities (2016 - 2025)

Odyssey Health (ODYY) recorded quarterly Cash from Investing Activities of $69787.0 in Q3 2025, down 93.02% quarter-over-quarter from $1.0 million in Q1 2024.

Odyssey Health (ODYY) Cash from Investing Activities (2016 - 2025) Analysis & Trends

Odyssey Health's Cash from Investing Activities history runs 5 years deep, the most recent figure standing at $69787.0 for Q3 2025.

  • In Q3 2025, Cash from Investing Activities changed N/A year-over-year to $69787.0; the TTM figure through Jul 2025 stood at $69787.0 (down 93.02% YoY), while the FY2025 annual figure was $69787.0, down 93.02% from the prior year.
  • Cash from Investing Activities was $69787.0 for Q3 2025 at Odyssey Health, down from $1.0 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $1.0 million in Q1 2024 to a low of -$45220.0 in Q1 2022.
  • Historically, Cash from Investing Activities has averaged $202901.2 across 4 years, with a median of -$2023.0 in 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Abbott Laboratories 152.92 Bn 146.27 Bn 6.27 Bn -20.32 Bn
2 Stryker 119.50 Bn 116.62 Bn 3.81 Bn -185.00 Mn
3 Medtronic 102.71 Bn 94.54 Bn 5.76 Bn -816.00 Mn
4 Boston Scientific 69.72 Bn 68.51 Bn 3.61 Bn -591.00 Mn
5 Edwards Lifesciences 49.24 Bn 45.57 Bn 1.29 Bn -92.80 Mn
6 GE HealthCare Technologies 29.74 Bn 27.67 Bn 1.98 Bn -2.50 Bn
7 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -475.32 Mn
8 Dexcom 28.96 Bn 27.84 Bn 750.30 Mn -298.50 Mn
9 Steris 20.31 Bn 19.88 Bn 697.10 Mn -217.20 Mn
10 Odyssey Health - - - -

Historic Data

Download Data
DateValue
Jul 31, 2025 69,787.00
Jul 31, 2025 69,787.00
Jan 31, 2024 1.00 Mn
Jan 31, 2024 1.00 Mn
Jul 31, 2023 -2,023.00
Jul 31, 2023 -2,023.00
Oct 31, 2022 -8,038.00
Oct 31, 2022 -8,038.00
Jan 31, 2022 -45,220.00
Jan 31, 2022 -45,220.00
Jul 31, 2016 -3,310.00
Jul 31, 2016 -3,310.00